<bill session="105" type="h" number="3925" updated="2013-07-14T18:50:56-04:00">
  <state datetime="1998-05-21">REFERRED</state>
  <status>
    <introduced datetime="1998-05-21"/>
  </status>
  <introduced datetime="1998-05-21"/>
  <titles>
    <title as="introduced" type="short">Prescription Drug Price Monitoring Commission Act of 1998</title>
    <title as="introduced" type="official">To establish the Prescription Drug Price Monitoring Commission.</title>
  </titles>
  <sponsor id="400026"/>
  <cosponsors>
    <cosponsor id="400003" joined="1998-10-14"/>
    <cosponsor id="400007" joined="1998-05-21"/>
    <cosponsor id="400525" joined="1998-08-05"/>
    <cosponsor id="400033" joined="1998-06-04"/>
    <cosponsor id="400542" joined="1998-09-17"/>
    <cosponsor id="400043" joined="1998-05-21"/>
    <cosponsor id="400050" joined="1998-06-04"/>
    <cosponsor id="400073" joined="1998-07-21"/>
    <cosponsor id="400548" joined="1998-05-21"/>
    <cosponsor id="400100" joined="1998-05-21"/>
    <cosponsor id="400110" joined="1998-05-21"/>
    <cosponsor id="404375" joined="1998-05-21"/>
    <cosponsor id="400502" joined="1998-07-21"/>
    <cosponsor id="400178" joined="1998-09-14"/>
    <cosponsor id="400537" joined="1998-07-16"/>
    <cosponsor id="400236" joined="1998-10-01"/>
    <cosponsor id="400240" joined="1998-05-21"/>
    <cosponsor id="400595" joined="1998-07-29"/>
    <cosponsor id="400301" joined="1998-07-16"/>
    <cosponsor id="400314" joined="1998-09-24"/>
    <cosponsor id="400357" joined="1998-07-16"/>
    <cosponsor id="400378" joined="1998-07-16"/>
    <cosponsor id="400387" joined="1998-05-21"/>
    <cosponsor id="400402" joined="1998-06-04"/>
    <cosponsor id="400410" joined="1998-10-01"/>
    <cosponsor id="400421" joined="1998-07-16"/>
    <cosponsor id="400436" joined="1998-06-19"/>
    <cosponsor id="400438" joined="1998-06-04"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="1998-05-21">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="1998-05-21">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="1998-05-21">
      <text>Referred to House Commerce</text>
    </action>
    <action datetime="1998-06-01">
      <text>Referred to the Subcommittee on Health.</text>
      <committee name="House Ways and Means"/>
    </action>
    <action datetime="1998-06-05">
      <text>Referred to the Subcommittee on Health and Environment, for a period to be subsequently determined by the Chairman.</text>
      <committee name="House Commerce"/>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSWM02" subcommittee="Health" name="House Ways and Means"/>
    <committee code="HSIF" name="House Commerce" activity="Referral, In Committee"/>
    <committee activity="Referral" code="HSIF04" subcommittee="Health and Environment" name="House Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Ambulatory care"/>
    <term name="Australia"/>
    <term name="Business income tax"/>
    <term name="Business records"/>
    <term name="Canada"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Cost accounting"/>
    <term name="Costs"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Economics and public finance"/>
    <term name="Electronic data interchange"/>
    <term name="Europe"/>
    <term name="European Union"/>
    <term name="Federal advisory bodies"/>
    <term name="Finance and financial sector"/>
    <term name="Foreign trade and international finance"/>
    <term name="Government operations and politics"/>
    <term name="Government paperwork"/>
    <term name="Health insurance"/>
    <term name="Income tax"/>
    <term name="Inflation"/>
    <term name="Latin America"/>
    <term name="Law"/>
    <term name="Licenses"/>
    <term name="Marketing"/>
    <term name="Marketing research"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Mexico"/>
    <term name="Oceania"/>
    <term name="Pharmaceutical research"/>
    <term name="Prescription pricing"/>
    <term name="Rebates"/>
    <term name="Research and development"/>
    <term name="Science, technology, communications"/>
    <term name="Social welfare"/>
    <term name="Subsidies"/>
    <term name="Tax credits"/>
    <term name="Tax incentives"/>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary>5/21/1998--Introduced.
Prescription Drug Price Monitoring Commission Act of 1998 - Establishes the Prescription Drug Price Monitoring Commission which shall conduct specified studies concerning U.S. pharmaceutical prices, including the establishment of a pharmaceutical products price review board. Terminates the Commission on a specified date. Directs the Secretary of Health and Human Services to study and report on Federal subsidies and incentives provided to the pharmaceutical industry. Amends title XIX (Medicaid) of the Social Security Act to require drug manufacturers participating in the Medicaid rebate program to report within a certain time after the end of each calendar year (currently, after each rebate period) on the average price at which the manufacturer sold each covered outpatient drug in Canada, Australia, Mexico, and the European Union countries.</summary>
</bill>
